Spero Therapeutics Inc. (SPRO)
NASDAQ: SPRO
· Real-Time Price · USD
1.93
-0.05 (-2.53%)
At close: Aug 15, 2025, 3:59 PM
2.00
3.88%
After-hours: Aug 15, 2025, 07:31 PM EDT
Spero Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 31.19M | 48.89M | 52.89M | 76.29M | 63.53M | 82.27M | 76.33M | 93.83M | 77.69M | 96.25M | 109.11M | 50.45M | 45.4M | 72.11M | 112.58M | 112.86M | 71.56M | 77.04M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 49.85M | 33.82M | 10.56M | 27.66M | 38.63M |
Long-Term Investments | n/a | n/a | n/a | n/a | 23.59M | 23.21M | 46.59M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 153K | 153K | 153K | 153K | 434K | 434K | 435K | 434K | 5.74M | 5.74M | 10.2M | 5.74M | 5.47M | 5.93M | 5.64M | 5.21M | 5.21M | 5.52M |
Receivables | 26.91M | 24.28M | 52.48M | 53.28M | 55.49M | 54.22M | 50.7M | 2.99M | 2.09M | 1.86M | 1.08M | 953K | 1.58M | 1.99M | 2.64M | 2.58M | 2.2M | 8.62M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.46M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 1.29M | 1.55M | 1.91M | 2.06M | 3.2M | 3.67M | 4.18M | 5.41M | 8.57M | 3.54M | 3.38M | 1.49M | 4.97M | 8.75M | n/a | 5.77M | 4.9M | n/a |
Total Current Assets | 59.4M | 74.71M | 107.28M | 131.63M | 122.22M | 140.15M | 131.21M | 102.22M | 88.35M | 101.66M | 109.11M | 52.89M | 51.95M | 132.7M | 157.87M | 131.77M | 106.32M | 129.49M |
Property-Plant & Equipment | 2.56M | 2.84M | 3.11M | 3.38M | 3.64M | 3.9M | 4.16M | 4.45M | 4.8M | 5.14M | 5.49M | 5.85M | 6.21M | 7.2M | 7.56M | 7.71M | 8.07M | 8.43M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 2.72M | 3M | 3.27M | 3.53M | 27.66M | 27.55M | 51.18M | 4.88M | 10.54M | 10.88M | 15.7M | 11.59M | 11.67M | 13.13M | 13.2M | 12.92M | 13.28M | 13.95M |
Total Assets | 62.12M | 77.71M | 110.54M | 135.16M | 149.88M | 167.7M | 182.39M | 107.1M | 98.89M | 112.55M | 124.8M | 64.48M | 63.63M | 145.83M | 171.07M | 144.69M | 119.59M | 143.44M |
Account Payables | 780K | 1.76M | 7.31M | 6.09M | 2.7M | 3.07M | 1.38M | 1.1M | 1.31M | 583K | 617K | 2.58M | 1.71M | 4.78M | 1.1M | 3.16M | 1.63M | 3.83M |
Deferred Revenue | 5.43M | 17.23M | 22.12M | 25.84M | 30.81M | 31.26M | 27.11M | 13.87M | 8.71M | 11.85M | 10.37M | 3.73M | 2.36M | 2.09M | 1.86M | 1.7M | 1.18M | -980K |
Short-Term Debt | 1.84M | n/a | n/a | n/a | n/a | 1.73M | 1.72M | 1.71M | 1.7M | 1.7M | n/a | 1.68M | 1.53M | 50.9M | n/a | 1.04M | 1.01M | 980K |
Other Current Liabilities | 2.54M | n/a | n/a | 12.05M | n/a | -1.73M | -1.72M | -1.71M | 4.47M | 3.81M | n/a | 1.69M | 4.89M | 58.56M | n/a | 6.29M | 5.5M | 10.66M |
Total Current Liabilities | 14.95M | 29.16M | 49.07M | 49.1M | 45.63M | 41.82M | 37.15M | 25.46M | 17.32M | 22.99M | 21.65M | 16.23M | 14.23M | 69.2M | 18.67M | 17.26M | 12.83M | 17.76M |
Long-Term Debt | 1.77M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | 12.57M | 576K | 13K | 25K | 38K | 87K | 62K | 72K | 85K | 96K | 107K | 117K | 128K | 49.35M | 148K | 158K | 168K |
Total Long-Term Liabilities | 14.35M | 14.74M | 15.35M | 20.56M | 23.75M | 29.63M | 38.34M | 27.93M | 26.78M | 24.72M | 27.22M | 15.77M | 13.48M | 14.16M | 64.11M | 15.54M | 16.52M | 6.83M |
Total Liabilities | 29.29M | 43.9M | 64.42M | 69.65M | 69.38M | 71.45M | 75.5M | 53.4M | 44.1M | 47.71M | 48.87M | 31.99M | 27.7M | 83.36M | 82.78M | 32.8M | 29.34M | 24.59M |
Total Debt | 3.62M | 3.96M | 4.3M | 4.62M | 4.94M | 5.24M | 5.54M | 5.83M | 6.11M | 6.38M | 6.65M | 6.9M | 7M | 7.09M | 7.33M | 7.23M | 7.44M | 7.64M |
Common Stock | 56K | 56K | 55K | 54K | 54K | 54K | 53K | 53K | 53K | 53K | 52K | 43K | 35K | 33K | 32K | 32K | 30K | 30K |
Retained Earnings | -475.2M | -473.5M | -459.64M | -438.75M | -421.6M | -403.74M | -391.07M | -442.26M | -439.06M | -427.14M | -413.88M | -440.65M | -428.97M | -400.29M | -367.46M | -338.22M | -315.7M | -297.13M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -6K | -2K | -2K | -2K | -3K |
Shareholders Equity | 32.83M | 33.81M | 46.12M | 65.51M | 80.5M | 96.25M | 106.89M | 53.7M | 54.78M | 64.84M | 75.93M | 32.48M | 35.92M | 62.47M | 88.29M | 111.89M | 90.25M | 118.85M |
Total Investments | n/a | n/a | n/a | n/a | 23.59M | 23.21M | 46.59M | n/a | n/a | n/a | n/a | n/a | n/a | 49.85M | 33.82M | 10.56M | 27.66M | 38.63M |